In 1984, the Hatch-Waxman Act created a streamlined regulatory pathway to allow domestic and overseas drug manufacturers to produce copycat versions once a brand-name drugs patent expires
Mukherjee D, Chakraborty S, Bercz L, DAlesio L, Wedig J, Torok MA, et al
Medically reviewed by Alan Lucks | MD , Alan Lucks MDPC Private Practice - New York on January 4th, 2026
Patients should continue their prescribed tirzepatide regimen unless specifically instructed otherwise by their healthcare provider based on their clinical status
[DOI] [PMC free article] [PubMed] [Google Scholar] 56.Madsbad S, Kielgast U, Asmar M, Deacon CF, Torekov SS, Holst JJ
Semaglutide belongs to a class of drugs called glucagon-like peptide-1 receptor agonists, or GLP-1 RAs